Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity

J Med Chem. 2021 Jun 10;64(11):7809-7838. doi: 10.1021/acs.jmedchem.1c00644. Epub 2021 May 27.

Abstract

We report on the design, synthesis, and biological evaluation of a series of nucleotide-binding oligomerization-domain-containing protein 2 (NOD2) desmuramylpeptide agonists with improved in vitro and in vivo adjuvant properties. We identified two promising compounds: 68, a potent nanomolar in vitro NOD2 agonist, and the more lipophilic 75, which shows superior adjuvant activity in vivo. Both compounds had immunostimulatory effects on peripheral blood mononuclear cells at the protein and transcriptional levels, and augmented dendritic-cell-mediated activation of T cells, while 75 additionally enhanced the cytotoxic activity of peripheral blood mononuclear cells against malignant cells. The C18 lipophilic tail of 75 is identified as a pivotal structural element that confers in vivo adjuvant activity in conjunction with a liposomal delivery system. Accordingly, liposome-encapsulated 75 showed promising adjuvant activity in mice, surpassing that of muramyl dipeptide, while achieving a more balanced Th1/Th2 immune response, thus highlighting its potential as a vaccine adjuvant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylmuramyl-Alanyl-Isoglutamine / chemistry*
  • Acetylmuramyl-Alanyl-Isoglutamine / metabolism
  • Acetylmuramyl-Alanyl-Isoglutamine / pharmacology
  • Adjuvants, Immunologic / chemistry*
  • Adjuvants, Immunologic / metabolism
  • Adjuvants, Immunologic / pharmacology
  • Animals
  • Antibody Formation / drug effects
  • Cell Line
  • Drug Design
  • Humans
  • Immunoglobulin G / metabolism
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / metabolism
  • Liposomes / chemistry
  • Lymphocyte Activation / drug effects
  • Mice
  • Mice, Inbred C57BL
  • Nod2 Signaling Adaptor Protein / agonists*
  • Nod2 Signaling Adaptor Protein / metabolism
  • Ovalbumin / immunology
  • Structure-Activity Relationship
  • Th1 Cells / cytology
  • Th1 Cells / immunology
  • Th1 Cells / metabolism
  • Th2 Cells / cytology
  • Th2 Cells / immunology
  • Th2 Cells / metabolism

Substances

  • Adjuvants, Immunologic
  • Immunoglobulin G
  • Interleukin-1beta
  • Interleukin-6
  • Liposomes
  • NOD2 protein, human
  • Nod2 Signaling Adaptor Protein
  • Acetylmuramyl-Alanyl-Isoglutamine
  • Ovalbumin